Sonic hedgehog (Shh) and its main receptor, Patched (Ptc), are implicated in both neural development and tumorigenesis 1,2 . Besides its classic morphogenic activity, Shh is also a survival factor 3,4 . Along this line, Ptc has been shown to function as a dependence receptor; it induces apoptosis in the absence of Shh, whereas its pro-apoptotic activity is blocked in the presence of Shh 5 . Here we show that, in the absence of its ligand, Ptc interacts with the adaptor protein DRAL (downregulated in rhabdomyosarcoma LIM-domain protein; also known as FHL2). DRAL is required for the pro-apoptotic activity of Ptc both in immortalized cells and during neural tube development in chick embryos. We demonstrate that, in the absence of Shh, Ptc recruits a protein complex that includes DRAL, one of the caspase recruitment (CARD)-domain containing proteins TUCAN (family member, 8) or NALP1 (NLR family, pyrin domain containing 1) and apical caspase-9. Ptc triggers caspase-9 activation and enhances cell death through a caspase-9-dependent mechanism. Thus, we propose that in the absence of its ligand Shh the dependence receptor Ptc serves as the anchor for a caspase-activating complex that includes DRAL, and caspase-9.
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Sonic hedgehog (Shh) and its main receptor, Patched (Ptc), are implicated in both neural development and tumorigenesis 1,2 . Besides its classic morphogenic activity, Shh is also a survival factor 3, 4 . Along this line, Ptc has been shown to function as a dependence receptor; it induces apoptosis in the absence of Shh, whereas its pro-apoptotic activity is blocked in the presence of Shh 5 . Here we show that, in the absence of its ligand, Ptc interacts with the adaptor protein DRAL (downregulated in rhabdomyosarcoma LIM-domain protein; also known as FHL2). DRAL is required for the pro-apoptotic activity of Ptc both in immortalized cells and during neural tube development in chick embryos. We demonstrate that, in the absence of Shh, Ptc recruits a protein complex that includes DRAL, one of the caspase recruitment (CARD)-domain containing proteins TUCAN (family member, 8) or NALP1 (NLR family, pyrin domain containing 1) and apical caspase-9. Ptc triggers caspase-9 activation and enhances cell death through a caspase-9-dependent mechanism. Thus, we propose that in the absence of its ligand Shh the dependence receptor Ptc serves as the anchor for a caspase-activating complex that includes DRAL, and caspase-9.
There are now more than a dozen identified dependence receptors, which include DCC 6 (deleted in colorectal cancer), UNC5H (uncoordinated 5 homologue), some integrins, neogenin, p75NTR (p75 neurotrophin receptor), RET (rearranged during transfection), ALK (anaplastic lymphoma kinase), EphA4 (ephrin type A receptor 4) and TrkC (tyrosine kinase receptor C) [7] [8] [9] [10] . They share several features in common (see reviews) 7, 8 : (i) these receptors create cellular states of dependence on their respective ligands as they induce programmed cell death in the absence of their ligands and this pro-apoptotic activity is inhibited in the presence of their ligands; (ii) these receptors are typically involved in both neural development and neoplasia; (iii) apoptosis induction requires a caspase-cleavage site in the intracytoplasmic domain.
Ptc fulfills all of these criteria as a candidate dependence receptor. The expression of Ptc induces apoptosis, which is suppressed by its ligand, Shh. Besides its key role during development, Ptc is a tumour suppressor and mutations of Ptc are associated with neoplasia, especially basal cell carcinomas 11 and medulloblastomas 12 . Moreover, apoptosis induction by Ptc requires the caspase-cleavage site at Asp 1392 (ref. 5) .
However, the mechanism by which the withdrawal of trophic ligands from their respective dependence receptors leads to apoptosis is largely unknown. Previous studies on DCC have suggested that some of these dependence receptors may recruit a caspase-activating complex 13 . This complex, comprising the initiator apical caspase-9, is independent of the two main apoptosis-related caspase-activating complexes, the DISC (death-induced signalling complex) and the apoptosome 14 . Yet, the precise identification of such an apoptosis-inducing dependence receptor complex has been unsuccessful so far.
In an attempt to identify pro-apoptotic signalling components downsstream of Ptc, a two-hybrid screen was performed using the pro-apoptotic domain of Ptc (residues 1165-1392; ref. 5 ) as bait and a human embryonic brain cDNA library as prey (Fig 1a) . Of the seven putative Ptc interactors ( Supplementary Information, Fig S1a) , we focused our attention on DRAL. Indeed, DRAL is a multifunctional protein that consists of four and a half LIM protein-protein interaction domains 15 . DRAL participates in cellular processes that include regulation of gene expression, cytoarchitecture, cell adhesion, cell mobility, signal transduction and cell survival 15 . Interestingly, DRAL overexpression seems to be pro-apoptotic in a variety of cells, however, the mechanism for DRALinduced apoptosis is unknown 16 . DRAL has also been shown to interact with TUCAN 17 , which was proposed to function as an adaptor protein for caspase-1 (ref. 18) or caspase-9 (ref. 19) .
To further confirm the interaction between the Ptc pro-apoptotic domain and DRAL, a targeted two-hybrid screen was performed. As shown in Fig. 1b , residues 1165-1392 of Ptc and DRAL interact in yeast. To monitor whether this interaction could be observed in mammalian cells, co-immunoprecipitation studies were performed on The Ptc-DRAL interaction was confirmed by a direct two-hybrid screen. AH109 yeasts were transformed with a mock Gal4BD plasmid and a Gal4AD plasmid fused with DRAL (DRAL), a mock Gal4AD plasmid and a Gal4BD plasmid fused with the Ptc pro-apoptotic domain (Ptc) or a Gal4AD plasmid fused with DRAL and a Gal4BD plasmid fused with Ptc (DRAL + Ptc). (c) Co-immunoprecipitations were performed on HEK293T cells transiently expressing Ptc-HA (Ptc) or DRAL-FlagM2 (DRAL) or Ptc-HA and DRAL-FlagM2 (Ptc + DRAL) in the absence (-) or presence (+) of Shh (300 ng ml -1 ). Pulldown with an anti-HA antibody was used to immunoprecipitate (IP) Ptc and DRAL was revealed by western blotting (WB) using an anti-FlagM2 antibody. Western blotting on lysates before pulldown are shown (Total). HEK293T cells co-transfected with tagged Ptc and DRAL. As shown in Fig. 1c , full-length DRAL was pulled down by full-length Ptc. When Shh was added to the culture medium, the Ptc-DRAL interaction was strongly decreased (Fig. 1c) . Similar interaction data were observed when the reverse immunoprecipitation was performed (Fig. 1d) . Moreover, as expected from the two-hybrid screen, the seventh intracellular region of Ptc, which includes the pro-apoptotic domain, was sufficient to interact with DRAL ( Supplementary Information, Fig. S1b ), whereas deletion of this region prevented the Ptc-DRAL interaction (Fig. 1e) .
Confocal analysis of the two co-expressed full-length proteins showed co-localization of Ptc and DRAL in HEK293T cells ( Fig. 1f ; Supplementary Information, Fig. S1c ). In an attempt to define the region of DRAL important for the Ptc-DRAL interaction, we tested whether DRAL lacking LIM domains 1 and 2 could be pulled down by Ptc. While deletion of the LIM1 domain had no effect on the Ptc-DRAL interaction, deletion of both LIM1 and LIM2 domains, or deletion of the LIM2 domain only, strongly decreased the ability of DRAL to interact with Ptc ( Fig. 1g; Supplementary Information, Fig. S1d ). Thus, both in yeast and in mammalian cells, Ptc interacts through its seventh intracellular domain with a region of DRAL that includes the LIM2 domain.
To address whether this interaction may be observed not only with ectopically expressed proteins but also with endogenous proteins, Ptc-DRAL co-localization was analysed in the Daoy medulloblastoma cell line in the absence or presence of Shh. In the presence of Shh, DRAL was mainly cytoplasmic and failed to co-localize with Ptc, in the absence of Shh, DRAL and Ptc clearly co-localized at the membrane of these cells ( Fig. 1h; Supplementary Information, Fig. S1e ). Similar results were obtained with primary cultured cerebellar granule cells (CGN; Fig. 1i ; Supplementary Information, Fig. S1f ). We then addressed the in vivo interaction of Ptc and DRAL using co-immunoprecipitation in mouse developing brain extract. Semi-dissociated embryonic day (E) 16.5 brains were either left untreated or exposed to Shh, and then further processed for Ptc immunoprecipitation. In the absence of Shh treatment, an anti-Ptc antibody pulled down DRAL, whereas Ptc-DRAL association was not observed with an unrelated isotypic antibody, confirming the specificity of the interaction. Addition of Shh inhibited the association of DRAL with Ptc (Fig. 1j) . Thus, Ptc directly interacts with DRAL both in cell culture and in the developing brain, and this interaction is prevented by Shh.
As a first assay to monitor the functional role of the Ptc-DRAL interaction, Ptc-induced cell death was assessed by Ptc transient expression in HEK293T cells 5 after DRAL gene silencing by short interfering RNA (siRNA). DRAL siRNA dramatically reduced endogenous DRAL expression in HEK293T cells, whereas the control siRNA did not (inset, Fig. 2a ). Ptc-induced cell death was reduced when DRAL was downregulated by siRNA (Fig. 2a) . In contrast to Ptc, overexpression of the classic cell-death inducer Bax triggered HEK293T cell death to a similar extent irrespective of DRAL siRNA expression. Thus, in immortalized cells, Ptc requires DRAL to trigger cell death.
We next analysed whether Ptc-induced cell death requires DRAL in vivo. Whereas it has been extensively demonstrated that Shh acts as a morphogen during nervous system development 1 , several studies have shown that Shh may also act as a survival factor 4, 20 . Consistently, it has been shown that the experimental withdrawal of Shh in chick embryos leads to massive death of neuroepithelial cells in the developing neural tube 3, 20 . We have demonstrated that this survival activity is due to Shh-induced inhibition of Ptc pro-apoptotic activity 5 . In initial studies, we and others used surgical procedures to prevent Shh production by the notochord and floor plate. We investigated whether a similar effect could be observed by the ectopic expression of HHIP1 (hedgehog-interacting protein 1), a protein known to inhibit Shh signalling through direct interaction 21 . The left side of the developing C o n t r o l B a x P t c C o n t r o l B a x P t c C o n t r o l B a x P t c C o n t r o l B a x P t c C o n t r o l B a x P t c C o n t r o l B a x P t c C o n t r o l B a x P t c C o n t r o l B a x P t c C o n t r o l B a x P t c C o n t r o l B a x P t c C o n t r o l B a x P t c C o n t r o l B a x P t c C o n t r o l B a x P t c C o n t r o l P t c C o n t r o l P t c 43 (d) HEK293T cells were transfected with an empty vector (control), Bax or Ptc either without treatment (-) or in the presence of zVAD-fmk (zVAD), scrambled siRNA (scramble), caspase-8 siRNA (si C8) or caspase-9 siRNA (si C9) and cell death was analysed using a trypan blue exclusion assay. Caspase-8 and 9 siRNA efficiencies are shown by western blotting using anticaspase-8 and 9 antibodies. An anti-actin western blot is shown as a control of specificity and loading. (e) HEK293T cells were co-transfected with an empty vector (control), Bax or Ptc plus either an empty vector (-), caspase-8 dominant-negative (C8 DN) or caspase-9 dominant-negative (C9 DN). Cell death was analysed as in d. In b-e, data are mean ± s.d., n = 3.
neural tube of HH11-13 chick embryos was co-electroporated in ovo with green fluorescent protein (GFP) and either a control or HHIP1 expression construct. Whereas GFP was detected after electroporation, a significant increase in apoptosis, measured by TUNEL (TdT-mediated dUTP nick end labelling) staining, was observed in HHIP1 electroporated neural tubes compared with mock electroporated embryos (as shown in Supplementary Information, Fig. S2a, b) . To further confirm that this HHIP1-dependent cell death was related to the loss of Shh inhibition of Ptc-induced apoptosis, a dominant-negative mutant of Ptc 5 was co-electroporated with HHIP1. Consistent with our previous data 5 , the Ptc dominant-negative mutant inhibited HHIP1-induced apoptosis ( Supplementary Information, Fig. S2a, b) . Thus, HHIP1 electroporation triggers Ptc-induced apoptosis in vivo. We then assessed the importance of DRAL in Ptc-induced cell death by co-electroporating HHIP1 with a DRAL short hairpin RNA (shRNA)-expressing construct that is effective at inhibiting chick DRAL expression ( Supplementary Information,  Fig. S2c ). Whereas scrambled shRNA failed to suppress HHIP1-induced apoptosis, DRAL shRNA significantly inhibited HHIP1-induced apoptosis ( Supplementary Information, Fig. S2a, b) . Moreover, similar inhibition by DRAL shRNA was observed when electroporation of HHIP1 was performed more ventrally through the use of an electrode located below the neural tube ( Supplementary Information, Fig. S2d ). It is, however, intriguing to note that HHIP1-electroporations were associated with cell death occurring mainly in the middle third and the dorsal third of the neural tube, but only modestly in the third ventral neural tube. The discrepancy between this apparent dorsal cell death and the higher Shh level detected ventrally, raised the possible limitation of Shh titration by HHIP1. However, similar cell-death inhibition after DRAL shRNA electroporation was observed when Shh production was reduced using a surgical procedure 3, 5 (Fig. 2bc) . Thus, together these data support the view that cell death induced after inhibition of Shh in the developing neural tube requires DRAL.
DRAL has been shown to interact with TUCAN, a protein initially thought to bind to caspase-9 (ref. 19 ). Because caspase-9 has been . Cell lysates were separated by gel filtration chromatography. Fractions were then analysed by western blotting for caspase-9, Ptc and Shh. The numbers of the fractions and the fractions in which the molecular mass markers were eluted are shown. (c) The 20 first fractions were pooled and Ptc pulldown experiments were performed. Anti-HA and anti-Myc immunoblots showed that caspase-9 and TUCAN interact with Ptc in these high molecular weight fractions. The relative quantity of proteins of interest (caspase-9 and TUCAN) in cell lysates of each condition was checked by immunoprecipitation and western blotting with anti-caspase-9 and anti-TUCAN antibodies, respectively. implicated in the pro-apoptotic activity of many dependence receptors 9,13 , we explored whether TUCAN might be part of a Ptc-DRAL complex that could allow the recruitment of caspase-9, using co-immunoprecipitation experiments with HEK293 cells. As shown in Fig. 3a , Ptc immunoprecipitation resulted in the pulldown of DRAL, TUCAN and caspase-9. Similarly, TUCAN immunoprecipitation pulled down Ptc and caspase-9 (Fig.3b) . Interestingly, the presence of Shh strongly inhibited the interaction between TUCAN and Ptc, while also decreasing the interaction between TUCAN and caspase-9 (Fig. 3ab) . Thus, in the absence of the dependence ligand Shh, Ptc allows the recruitment of a complex that includes DRAL, TUCAN and caspase-9.
TUCAN is composed of two main domains: a FIIND domain located in the amino-terminal region and a CARD domain at the carboxyl terminus which is known to interact with caspases (see scheme, Fig. 3c ). Interestingly, deletion of the N-terminal region of TUCAN is sufficient to abrogate the interaction of Ptc-DRAL with TUCAN (Fig. 3d) . This N-terminal domain is closely related to a domain found in NALP1 (NLR family, pyrin domain containing 1; 66% homology in human), another CARD domain-containing protein known to recruit caspases that has been implicated in both cell death regulation and inflammation 22, 23 ( Fig. 3c) . Using a similar co-immunoprecipitation approach, NALP1 was also pulled down with Ptc, but this interaction was strongly reduced in the presence of Shh (Fig. 3e, f) . A control for specificity, ASC (apoptosis speck protein) a protein related to NALP1, failed to interact with Ptc (Fig. 3c, g ). Interestingly, whereas TUCAN-knockdown by TUCAN siRNA expression (Fig. 4a) , was not sufficient to fully and reproducibly inhibit Ptc-induced cell death (data not shown), TUCAN and NALP1 siRNA co-expression completely inhibited the cell death observed after Ptc transfection in HEK293T cells (Fig. 4bc) . Thus, NALP1 or TUCAN behave as adaptor proteins of the Ptc-DRAL complex, which includes caspase-9 and seems to be required for Ptc-induced cell death. Even though TUCAN and NALPs have been implicated in the classic survival pathway NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells) regulation 22, 24 we were able to exclude a putative link between the NF-κB pathway and the regulation of Ptc pro-apoptotic activity ( Supplementary Information, Fig. S4a-c) . Moreover, because TUCAN and NALP1 have been shown to also interact with caspase-1 (refs 18, 22, 25), we next investigated the specificity of caspase-9 recruitment to Ptc. Although Ptc interacted with caspase-9 after expression in HEK293T cells, Ptc failed to pulldown caspase-1 (Fig. 3g) . Thus, the Ptc-DRAL interaction represents an anchor for a specific TUCAN/ NALP1-caspase-9-containing complex.
To assess the importance of this DRAL-TUCAN/NALP1-caspase-9 complex in Ptc-mediated cell apoptosis, we next assessed whether Ptcinduced apoptosis requires caspase-9. As shown in Fig. 4d , whereas Ptcinduced cell death in HEK293T cells (and Bax-induced cell death as a control) was not modulated by siRNA-induced caspase-8 knockdown, it was strongly inhibited by siRNA-induced caspase-9 knockdown (Fig.4d  inset) . Similar results were obtained when dominant-negative mutants for caspase-8 and caspase-9 were used instead of siRNAs (Fig. 4e) or when using chemical caspase inhibitors (data not shown). To further address the requirement of caspase-9 in a biological system where endogenous Ptc induces apoptosis after Shh deprivation, developing neural tubes of HH11-13 chick embryos were co-electroporated in ovo by GFP and a HHIP1 expression construct together with a dominantnegative mutant for caspase-9. While HHIP1 electroporation triggered apoptosis, co-electroporation with the mutant strongly inhibited Ptcmediated apoptosis ( Supplementary Information, Fig. S5a, b) .
Given that Ptc interacts with caspase-9 (through a DRAL-TUCAN/ NALP1 complex) and that Ptc requires caspase-9 to trigger apoptosis both in immortalized cells in culture and in the developing neural tube in vivo, we hypothesized that ligand-free Ptc activates caspase-9. To investigate this possibility, we analysed the activity of caspase-9 by measurement of LEHD-AFC substrate cleavage in HEK293 cells transfected with Ptc. As shown in Fig. 5a , Ptc triggered caspase-9 activity whereas the presence of Shh strongly decreased this Ptc-induced effect. We next analysed whether this activation is associated with the formation of large caspase-9-containing complexes, by analogy to other initiator caspase-activating complexes 26 . To this end, gel-exclusion chromatography analysis of caspase-9 was performed using lysates from control and Ptc-expressing HEK293 cells. Although in the absence of Ptc, caspase-9 was detected at a small exclusion size (relative molecular mass, M r , 50,000-100,000, 50K-100K), the presence of Ptc triggered a shift of caspase-9 toward the higher molecular weight fractions, such that caspase-9 was also detected to have M r in the 1000K-2000K size fraction (Fig. 5b) . As a negative control, Ptc deleted of its pro-apoptotic domain (seventh intracellular domain) failed to trigger this shift toward larger fractions (Fig. 5b) . Moreover, the presence of caspase-9 in higher fractions observed on Ptc expression was inhibited in the presence of Shh (Fig.5b) . Interestingly, in the absence of Shh, when caspase-9 was detected in the high molecular weight fractions, caspase-9 was present in a complex containing Ptc and TUCAN, as shown by co-immunoprecipitation experiments (Fig. 5c) . When endogenous caspase-9 was pulled down by Ptc, the caspase-9 recruited in the Ptc complex was proteolytically processed ( Supplementary Information, Fig. S6 ), further confirming that, in the absence of Shh, Ptc induces a complex of high molecular mass that includes DRAL and TUCAN (and/or NALP1), which results in caspase-9 activation.
Our data support the view that cell-death initiation by the Ptc dependence receptor occurs through the recruitment of a protein complex that results in the activation of caspase-9. In this regard, caspase-9 is an initiator or apical protease involved in the control of a downstream cascade of caspase activation that leads to apoptosis. Initiator caspases are typically activated through formation of large multi-protein complexes (see review) 27 . Among the known caspase-activating complexes of mammals are the apoptosome (comprising Apaf-1, cytochrome c and caspase-9), the DISC (comprising Fas, FADD and caspase-8; ref. 14), the PIDDosome (comprising PIDD, RAIDD and caspase-2; ref. 28 ) and the inflammasome (comprising NALPs, ASC, caspase-1 and caspase-5; ref. 22 ). Here we report the existence of a fifth caspase-activating complex that signals downstream of the dependence receptor Ptc. Future work will aim to define whether this 'dependosome' is a common platform for dependence-receptor death signalling, as suggested by the interaction of DCC with caspase-9 and the requirement of caspase-9 for DCC to trigger cell death 13 . In addition to the adaptor protein DRAL, the Ptc-based activating complex also requires either TUCAN or NALP1. Whereas TUCAN directly binds to pro-caspase-9 through their CARD-domains, NALP1 has been reported to indirectly bind through association with the procaspase-9-binding protein Apaf-1 (ref. 29) . Whether Apaf-1 can also be recruited to the Ptc-dependence receptor complex remains to be investigated. Similarly, it will be interesting to determine the stoichiometry of the Ptc complex that activates caspase-9, as the observation that caspase-9 is detected in a complex of M r 1000K-2000K in Ptc-expressing cells suggests the formation of a multimeric complex, similar to other caspaseactivating platforms. 
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Site directed mutagenesis and plasmid constructs. The different constructs used in this study are detailed in Supplementary Information, Methods. The pcDNA3-Ptc-7ICmyr construct was obtained by polymerase chain reaction (PCR) on the pcDNA3-Ptc-7IC plasmid with the primers Ptc-myr7IC-F and Ptc-7IC-HA-R. The Ptc mutant with the deletion of its seventh intracellular domain (7IC; pRK5-PtcΔ7IC) was obtained by directed mutagenesis through Quikchange strategy (Stratagene) on pRK5-Ptc with mPtc1-∆7IC-F and mPtc1-∆7IC-R. For two-hybrid screening, the coding sequence of Ptc-7IC from pcDNA3-Ptc-7IC was amplified by PCR using the primers mPtc1-Eco-7IC-F and mPtc1-Pst-7IC-R and then inserted into pGBKT7 plasmid by digestion through EcoRI-PstI. By directed mutagenesis using Quikchange strategy on the resulting plasmid, a stop amino acid was generated in position 1393, to obtain the pGBKT7-GAL4 DNA-binding domain-Ptc 1165-1392 fusion plasmid (for primers sequence mPtc1-1393StopQC-F and mPtc1-1393StopQC-R, see Supplementary Information, Table S1 ). The construct pcDNA3-DRAL-3×FlagM2ΔLIM2 deleted only of its LIM2 domain was obtained by directed mutagenesis with Quikchange strategy using the primers DralΔLim2-F and DralΔLim2-R on the plasmid pcDNA3-DRAL-3×FlagM2 as matrix. A pcDNA3 plasmid encoding haemagglutinin (HA)-tagged DRAL from chicken was generated by PCR on cDNAs of one-day-old chick embryos by using the primers Chick-DRAL-F and Chick-DRAL-R. This plasmid was used as matrix to be amplified by PCR DRAL-encoding sequence using the primers pCAGGS-Chick-DRAL-XhoI-F and pCAGGS-Chick-DRAL-BglII-R. The PCR product was inserted into a pCAGGS vector. The pcDNA3-TUCANΔNTer plasmid was obtained by PCR using the primers TUCANΔNTerm-F and TUCANΔNTerm-Myc-R on the pcDNA3-TUCANMyc plasmid. For the in ovo chick electroporation, most constructs were based in pCAGGS which was also used as empty vector. pCAGGS-caspase-9 dominant negative was constructed by subcloning from pcDNA3-caspase-9 dominant negative 13 into a pCAGGS vector. Primers to construct pSilencer1.0-U6 containing small interfering hairpins of DRAL mRNA were designed with siRNA Target Designer program (Promega). See Supplementary Information, Table S1 for primers.
Cell cultures, transfection procedures, reagents and immunoblotting. Transient transfection of HEK293T cells and HEK293 cells expressing Muristerone
A-inducible Shh (HEK293-EcRShh) was performed as described previously 5 . Daoy cells (ATCC, #HTB-186) were grown in 10% DMEM media on poly-Llysine (Sigma)-coated round coverslips. Primary cultured cerebellar granule neurons (CGNs) were prepared from P6-aged mice (NMRI). 5e1 hybridoma cells producing a Shh-blocking antibody (Developmental Studies Hybridoma Bank), were maintained in 20% DMEM. Immunoblotting was performed as described previously 6 , except antibodies were obtained from different sources and different dilutions were used (Supplementary Information, Methods). Recombinant Shh-N was from R&D systems. To induce Shh production in HEK293-EcRShh cells, Muristerone A (A.G. Scientific Inc.) was used (1 μM).
Yeast two-hybrid screen and co-immunoprecipitation. Matchmaker two-hybrid system III (Clontech) was used according to the manufacturer's instructions, using the DNA-binding domain GAL4 fused to Ptc residues 1165-1392 as a bait and the GAL4 transcriptional activation domain AD fused to a human fetal brain cDNA library (Clontech) as prey. In vitro co-immunoprecipitation were carried out on HEK293T or HEK293-EcRShh cells transfected with various tagged constructs as described previously 13 . For experiments requiring Shh, after plating and at the time of transfection cells were untreated or treated with Muristerone A, and recombinant Shh was added (to a final concentration of 300 ng ml -1 ) 24 h before collecting the cells. In vivo immunoprecipitations were performed in OF-1 mice cortex embryos. Two cortices were dissected from embryonic day (E) 16.5 embryos, cut in small species and triturated. Shh-treated cortices were incubated for 40 min at 37 °C in conditioned supernatant of HEK293-EcRShh-induced cells in which recombinant Shh-N (R&D systems) was added (900 ng per cortex). Non-treated cortices were incubated in the same condition in supernatant of non-induced HEK293-EcRShh cells and without addition of recombinant Shh-N. Dissociated cortices were further processed for immunoprecipitation using μMACS Protein G MicroBeads system (Miltenyi Biotec).
Co-localization studies. After transfection or treatment as described in Supplementary Information, Materials, HEK293T , Daoy or CGNs cells were fixed in 4% paraformaldehyde for 30 min, washed and permeabilized with 0.2% Triton X-100 in PBS for 30 min. The coverslips were mounted in crystal/mount (Biomeda) and photographed with a Zeiss Axioplan2 LSM510 confocal microscope. Profiles were created using Axiovision 4.0V4.6.1.0 program.
Gel filtration.
Gel filtrations were performed as described in Supplementary Information, Materials, using size-exclusion chromatography on High Prep Sephacryl S300 (HR 16/60) columns using an FPLC protein purification system (Biologic HR, Biorad). Proteins were separated with the lysis buffer. Columns were calibrated with protein standards (29K-2000K) according to the manufacturer's instructions (Sigma). Aliquots of the fractions were analysed on Criterion XT Precast gels (Bis-Tris 4-12%; Biorad) and western blotting. Aliquots of the twentieth first fractions were also pooled and used for co-immunoprecipitation experiments as described for in vitro co-immunoprecipitation.
Cell death analysis and caspase assays. Cell death was analysed 24 h after transfection using trypan blue staining procedures as described previously 5 . Cell death was also analysed using Toxilight assay (Lonza) according to the manufacturer's instructions. For caspase-9 activity fluorometric assay, HEK293-EcRShh cells were treated twice (when seeded and when transfected) with Muristerone A for the condition with Shh, and recombinant Shh-N (300 ng ml -1 ) was added 1 h before collecting the cells. Caspase-9 activity was then measured by using the caspase-9 fluorometric assay kit (BioVision). Caspase-3 activity was measured by using the caspase-3 fluorometric assay kit (BioVision) as described previously 5 .
Chick in ovo experiments and TUNEL staining on chick embryos. Cell-death analysis in the developing chick neural tube was performed using fertilized chicken eggs obtained from a local farm and incubated at 38 °C. Embryos were staged according to Hamburger and Hamilton (HH). Chick embryos were electroporated with purified plasmid DNA (4.5 μg μl -1 ; Sigma). For floor plate electroporation, chick embryos of stage HH10-11 were injected with plasmid DNA into the lumen of the neural tube and electroporated with specifically designed electrodes. In each condition, GFP was co-electroporated to check the electroporation efficiency. Chick microsurgery was done as described in previously 5 , except that the electroporation performed before microsurgery was performed in only one side of the neural tube. Detection and quantification of apoptosis by TUNEL was performed using the In Situ Cell Death Detection Kit (Roche) as described previously 3 . For each embryo, GFP and TUNEL double-positive cells of the electroporated and non-electroporated sides of the neural tube were counted in more than six sections. The ratio of the number of TUNEL-positive cells from the electroporated side to that of the non-electroporated side was then calculated. For each condition, results from at least five embryos were used to calculate a mean of the ratio. A U test was done to evaluate if the difference between various conditions was significant. Fluorescent TUNEL was performed as described previously 30 . NF-kB luciferase reporter assays. Analysis of NF-kB activation was performed according standard luciferase reporter assays as described in Supplementary Information, Methods. Co-immunoprecipitations between Ptc and endogenous caspase-9 were performed on HEK293T cells lysates transiently transfected with either empty vector (Cont.) or Ptc-encoding vector (Ptc) using anti-Ptc antibody (IP αPtc). Caspase-9 was detected by Western blotting using anti-caspase-9 antibody which recognizes both the full length and cleaved forms of caspase-9. Full length caspase-9 (Procaspase-9) and cleaved forms of caspase-9 (cleaved caspase-9) were co-immunoprecipitated by Ptc pull-down. The molecular weight of each form of caspase-9 is indicated.
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Supplementary Table1: and Western blotting. Aliquots of the 20 th first fractions were also pooled and used for co-immunoprecipitation experiments as described for in cellulo coimmunoprecipitation.
Cell death analysis and caspase assays.
Cell death was analyzed 24h after transfection using trypan blue staining procedures as described previously Caspase-3 activity was measured by using the caspase-3 fluorometric assay kit (BioVision) as described previously 1 .
Chick in ovo experiments and TUNEL staining on chick embryos.
Cell death analysis in the developing chick neural tube was performed using fertilized chicken eggs obtained from a local farm and incubated at 38°C.
Embryos were staged according to Hamburger and Hamilton (HH). Chick embryos were electroporated with Sigma purified plasmid DNA (4.5 µg/µl) with 50 ng/ml Fast Green. For floor plate electroporation, chick embryos of stage HH10-11 were injected with plasmid DNA into the lumen of the neural tube and electroporated with specifically designed electrodes. These electrodes allowed us to fit the anode under the embryo and to lay the cathode on the embryo with 3 mm spacing. We carried out electroporation with 4 pulses of 50 ms duration at 20
